Paul Bradley, MD, Enrolls First Participant in Moderna’s Phase 3 COVID-19 Vaccine Clinical Trial

The first participant in the Moderna Phase 3 COVID-19 vaccine trial was enrolled this morning by Dr. Paul Bradley, Principal Investigator at Meridian’s (now Velcoity Clinical Research) internal medicine site in Savannah, GA. Compliments to Moderna on this significant milestone for its mRNA vaccine candidate (mRNA-1273) against COVID-19. 📰 Full release:

Posted in

Quality. Continuity. Velocity.